Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Rectal Neoplasms 5Colorectal Neoplasms 4Barrett Esophagus 3Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Urogenital Neoplasms 1Upper Tract Urothelial Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Primary Effusion 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Lung Neoplasms 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Fistula 1Esophageal Squamous Cell Carcinoma 1Disease 1Colitis 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Non-Small-Cell Lung 1Bacteremia 1Adenoma 1Adenocarcinoma 1

Interventions

Vincristine 3Rituximab 3Prednisone 3Etoposide 3Doxorubicin 3Cyclophosphamide 3Filgrastim 2prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal doxorubicin 1ibrutinib 1etoposide phosphate 1deltacortene 1Ultrasonography 1Lenalidomide 1Granulocyte Colony-Stimulating Factor 1Endoscopy 1Electrocardiography 1Echocardiography 1CT-P10 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, AIDS-Related × Endoscopy × 1 year × Clear all
NCT02911142 2025-07-28

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
17 enrolled 21 charts
Lymphoid

Lymphoma, B-Cell, Lymphoma, AIDS-Related, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡